397 related articles for article (PubMed ID: 29545123)
1. Mucormycosis in Iran: A six-year retrospective experience.
Dolatabadi S; Ahmadi B; Rezaei-Matehkolaei A; Zarrinfar H; Skiada A; Mirhendi H; Nashibi R; Niknejad F; Nazeri M; Rafiei A; Gharaghani M; Erami M; Taghipour S; Piri F; Makimura K
J Mycol Med; 2018 Jun; 28(2):269-273. PubMed ID: 29545123
[TBL] [Abstract][Full Text] [Related]
2. Mucormycosis in Iran: a systematic review.
Vaezi A; Moazeni M; Rahimi MT; de Hoog S; Badali H
Mycoses; 2016 Jul; 59(7):402-15. PubMed ID: 26906121
[TBL] [Abstract][Full Text] [Related]
3. Identification of Mucorales in patients with proven invasive mucormycosis by polymerase chain reaction in tissue samples.
Gholinejad-Ghadi N; Shokohi T; Seifi Z; Aghili SR; Roilides E; Nikkhah M; Pormosa R; Karami H; Larjani LV; Ghasemi M; Haghani I
Mycoses; 2018 Dec; 61(12):909-915. PubMed ID: 30091261
[TBL] [Abstract][Full Text] [Related]
4. Frequency of occurrence, seasonal variation and antifungal susceptibility of opportunistic Mucorales isolated from hospital soils in Iran.
Vaezi A; Walther G; Kurzai O; Mahdi D; Dadashzadeh M; Nasri E; Diba K; Badali H; Fakhim H
Mycoses; 2021 Jul; 64(7):780-787. PubMed ID: 33835599
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
[TBL] [Abstract][Full Text] [Related]
6. Features and evaluation of mucormycosis in COVID-19 patients from two referral hospitals in Iran.
Fakhim H; Irani S; Yassin Z; Badali H; Nasri E; Nasoori Y; Samimiardestani S; Mohebbi S; Mohammadi Ardehali M; Alizadeh Pahlavan P; Firouzifar M; Tajdini A; Ahadi S; Vaezi A
J Mycol Med; 2024 Jun; 34(2):101480. PubMed ID: 38744060
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
Chowdhary A; Kathuria S; Singh PK; Sharma B; Dolatabadi S; Hagen F; Meis JF
Mycoses; 2014 Dec; 57 Suppl 3():97-107. PubMed ID: 25250768
[TBL] [Abstract][Full Text] [Related]
8. [Not Available].
Gholinejad Ghadi N; Seifi Z; Shokohi T; Aghili SR; Nikkhah M; Vahedi Larijani L; Ghasemi M; Haghani I
J Mycol Med; 2018 Jun; 28(2):399-402. PubMed ID: 29545122
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
Bala K; Chander J; Handa U; Punia RS; Attri AK
Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
[TBL] [Abstract][Full Text] [Related]
10. Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases.
Bonifaz A; Tirado-Sánchez A; Hernández-Medel ML; Araiza J; Kassack JJ; Del Angel-Arenas T; Moisés-Hernández JF; Paredes-Farrera F; Gómez-Apo E; Treviño-Rangel RJ; González GM
Mycoses; 2021 Apr; 64(4):372-380. PubMed ID: 33253454
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases.
Corzo-León DE; Chora-Hernández LD; Rodríguez-Zulueta AP; Walsh TJ
Med Mycol; 2018 Jan; 56(1):29-43. PubMed ID: 28431008
[TBL] [Abstract][Full Text] [Related]
12. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.
Prakash H; Ghosh AK; Rudramurthy SM; Singh P; Xess I; Savio J; Pamidimukkala U; Jillwin J; Varma S; Das A; Panda NK; Singh S; Bal A; Chakrabarti A
Med Mycol; 2019 Jun; 57(4):395-402. PubMed ID: 30085158
[TBL] [Abstract][Full Text] [Related]
13. A case of rhinoorbital mucormycosis in a leukemic patient with a literature review from Turkey.
Gumral R; Yildizoglu U; Saracli MA; Kaptan K; Tosun F; Yildiran ST
Mycopathologia; 2011 Nov; 172(5):397-405. PubMed ID: 21761152
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 30 cases of mucormycosis at a university hospital in Iran.
Samarei R; Gharebaghi N; Zayer S
Mycoses; 2017 Jul; 60(7):426-432. PubMed ID: 28321926
[TBL] [Abstract][Full Text] [Related]
15. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E;
BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748
[TBL] [Abstract][Full Text] [Related]
16. Mucormycosis experience through the eyes of the laboratory.
Sağıroğlu P; Nedret Koç A; Atalay MA; Altinkanat Gelmez G; Canöz Ö; Mutlu Sarıgüzel F
Infect Dis (Lond); 2019 Oct; 51(10):730-737. PubMed ID: 31364897
[No Abstract] [Full Text] [Related]
17. Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales).
Chander J; Stchigel AM; Alastruey-Izquierdo A; Jayant M; Bala K; Rani H; Handa U; Punia RS; Dalal U; Attri AK; Monzon A; Cano-Lira JF; Guarro J
Rev Iberoam Micol; 2015; 32(2):93-8. PubMed ID: 25576377
[TBL] [Abstract][Full Text] [Related]
18. Mucormycosis in Cairo, Egypt: review of 10 reported cases.
Zaki SM; Elkholy IM; Elkady NA; Abdel-Ghany K
Med Mycol; 2014 Jan; 52(1):73-80. PubMed ID: 23848229
[TBL] [Abstract][Full Text] [Related]
19. [Treatment review in rhinocerebral mucormycosis].
Pardal Refoyo JL; Chocarro Martínez A; Brezmes Valdivieso MF; Parra Pérez C
An Otorrinolaringol Ibero Am; 1998; 25(1):45-56. PubMed ID: 9542247
[TBL] [Abstract][Full Text] [Related]
20. Mucormycoses.
Eucker J; Sezer O; Graf B; Possinger K
Mycoses; 2001; 44(7-8):253-60. PubMed ID: 11714058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
